Can This Approach Help? Inside the Latest Research on Clinical Performance of Tissue- and Plasma-Based Diagnostic Assays in Identifying
Clinically meaningful benefits for all end points were comparable for BRCA + and HRR + patients detected by.
Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Clinically meaningful benefits for all end points were comparable for BRCA + and HRR + patients detected by.
Low-dose GMRx2 provides superior BP reduction and a well-tolerated safety profile in patients with mild to moderate high blood pressure.
These findings indicate that chronic kidney disease-associated severe itching intensity is linked to systemic inflammation, potentially through a neuroimmune crosstalk mechanism.
This novel trial design may deliver valuable data on the neuroprotective potential of nicotinamide and pyruvate supplementation in glaucoma and improve our understanding of optimal study design for longitudinal randomized...
Vitamin D supplementation was associated with increased circulating 25(OH)D concentrations, whereas current evidence is insufficient to support a consistent improvement in physical performance. Given the low to very low certainty of evidence, these findings should be interpreted cautiously.
Propofol-fentanyl provides faster induction and LMA insertion, whereas sevoflurane offers superior blood flow and heart rate stability with comparable safety profiles in children patients.
This study did not demonstrate a definitive survival benefit from systematic lymphadenectomy in advanced OCCC patients with complete resection and clinically negative nodes.
The observed heterogeneity in contouring and RT-planning highlights the need for rigorous QA.
There were no particular safety issues as reported in the phase 2/3 study and no clear deterioration in survival rate or physical function when ultra-high-dose methylcobalamin was administered intramuscularly in patients with...
The RSF model effectively identified women at high risk of requiring insulin.
These data support the potential optimization of China's immunization strategy by transitioning from co-purified to component-based acellular pertussis vaccines to address waning immunity and the ongoing pertussis resurgence.
In a Bayesian reanalysis of the PINETREE trial, there was a 98.9% or greater probability that treatment with RDV reduced the risk of COVID-19-related hospitalization or all-cause death across all prior probability distributions.
The population PK model developed using baricitinib concentrations from adult patients, with allometric scaling for weight on clearance and volume, adequately predicted exposures in the children population.
TTVA vaccine has good immunogenicity in people aged 18 years and above.
A comprehensive WASH intervention implemented for three years in rural Ethiopia did not improve growth among children 0-5 years old.
2.1%, p = 0.0421), rather than an increase in incidence (HR = 1.09, p = 0.2669).
Upadacitinib effectively reduced pain in active RA and PsA, including in patients with AoI.
Patients without radiographic progression through 2 years of secukinumab treatment had greater achievement of LDA states at week 104 than patients with radiographic progression.
MRNA-1283.815 elicited noninferior neutralizing antibody responses to mRNA-1273.815 against Omicron XBB.1.5 at Day 29, meeting the primary immunogenicity objective, with the GMR indicating higher responses of mRNA-1283.815 vs...
These results validate JSpADA as a disease activity measure for children with ERA and jPsA in a prospective clinical trial setting.
This study suggests that lumateperone can be considered an effective and safe adjuvant treatment for MDD.
In addition to a significant and sustained day and night-time ambulatory BP reduction, aprocitentan was associated with a higher proportion of patients experiencing dipping pattern normalization and more pronounced BP load...
In a low-mortality setting, there was not clear evidence that neonatal BCG vaccination significantly reduces the incidence of early life hospitalisation for LRTI, infections or breathing illness.
Semaglutide significantly improves BMI and lipid profiles in PCOS, particularly at higher doses, and in obese patients.
CONCLUSION: Our extensive pharmacogenomic/PK/safety analysis in patients with AML does not indicate the need for dose adjustments of midostaurin based on CYP3A4/CYP3A5 polymorphic variants.
ATSB Sarabi v.1.2 as deployed in western Zambia were not likely to be cost -effective.
In women with obesity and PCOS, semaglutide improved an overall taste recognition score, altered RNA expression in the tongue and modified brain activity in response to sweet and savory food cues and to tasting sweet solution.
Tolvaptan was associated with large increases in free water clearance and urine output.
This novel truncated protein, previously unreported in the literature, is associated with the disruption of the Wnt pathway and T-cell receptor signaling, which can be exploited as a therapeutic strategy to enhance...
WWI is closely associated with future heart and blood vessel outcomes and TM in patients with T2DM.WWI serves as an autonomous predictor of both future heart and blood vessel events and TM among patients with T2DM,...
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.